Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

In a move signaling a strategic expansion, Mainline Instruments and Oculus Optikgeräte have announced the extension of their successful partnership into the ophthalmology sector for the UK and Ireland markets. This collaboration aims to introduce cutting-edge ophthalmic solutions, catering to…

In 2023, the ophthalmic industry witnessed a transformative landscape shaped by strategic company acquisitions, setting the stage for significant advancements and collaborations. The top 10 acquisitions of the year highlighted a dynamic shift in the competitive dynamics of the sector.…

Glaukos has received FDA approval for iDose TR (travoprost intracameral implant 75 mcg), a groundbreaking prostaglandin analog intracameral implant designed to reduce intraocular pressure (IOP) in individuals with ocular hypertension or open-angle glaucoma. The iDose TR procedure, sanctioned for a…
The field of ophthalmology is constantly evolving with new technologies and treatments emerging every year. In the next decade, we can expect even more advancements that will revolutionize the way we approach eye care. Here are the top 10 eye…

In a recent survey conducted on LinkedIn by the Ophthalmology Breaking News (OBN), ophthalmology professionals were asked to identify the emerging technology they believed held the most promise for improving surgical outcomes in their field. The results shed light on…

Cataract surgery has undergone remarkable advancements, leading to significant improvements in patient outcomes and revolutionizing the field of ophthalmology. From advanced surgical techniques to innovative intraocular lens (IOL) options, this article explores the top six breakthroughs in cataract surgery that…

Ophthalmologists, often referred to as eye doctors, are healthcare professionals who specialize in the diagnosis, treatment, and management of eye diseases and disorders. While we may visit them for routine eye exams or specific vision concerns, the world of ophthalmology…

The US Food and Drug Administration (FDA) has taken action to update the warning label on Horizon Pharmaceutical’s TEPEZZA, a drug used to treat thyroid eye disease (TED), to include the risk of hearing impairment or loss. The recent addition…

Genentech announced that the FDA has accepted the company’s supplemental biologics license application (sBLA) for Vabysmo (faricimab-svoa) for the treatment of macular edema following retinal vein occlusion (RVO). The sBLA is based on data from the phase 3 BALATON and…

Alimera Sciences has reached its enrollment target for the Synchronicity study, marking a significant milestone in the prospective, open-label clinical investigation of Yutiq (fluocinolone acetonide intravitreal implant 0.18mg). The study focuses on assessing the safety and efficacy of Yutiq in…